What are the recommended treatment options and dosing guidelines for Graves' disease, including antithyroid medications, radioactive iodine therapy, and thyroidectomy?

Treatment of Graves' Disease

Graves' disease requires definitive treatment with one of three modalities: antithyroid drugs (methimazole or propylthiouracil), radioactive iodine (RAI), or thyroidectomy, with the choice depending primarily on patient age, pregnancy status, goiter size, presence of thyroid eye disease, and patient preference. 1

Initial Medical Management

Antithyroid Drugs (Thionamides)

Methimazole is the preferred first-line antithyroid drug for most non-pregnant adults due to its longer half-life allowing once-daily dosing and similar efficacy to propylthiouracil. 2, 1

• Treatment duration: 12-18 months using the titration method (lowest dose maintaining euthyroidism). 3, 1
• Expected remission rate: Approximately 50% of patients achieve long-term remission after completing a course of antithyroid drugs. 3, 1
• Monitoring: Check free T4 or free thyroxine index every 2-4 weeks during initial treatment to maintain levels in the high-normal range using the lowest possible dose. 4

Critical adverse effects requiring immediate discontinuation:

• Agranulocytosis (presents with sore throat and fever—obtain complete blood count immediately and stop the drug). 4
• Hepatitis, vasculitis, and thrombocytopenia. 4
• Most adverse effects occur within the first 90 days of therapy. 1

Symptomatic Management

Beta-blockers (propranolol or atenolol) should be used for symptomatic relief of tachycardia, tremor, and anxiety until thyroid hormone levels normalize. 4

Definitive Treatment Options

Radioactive Iodine (RAI) Therapy

RAI is the preferred definitive treatment for most adults in the United States due to its simplicity, safety, effectiveness, and cost-effectiveness compared to long-term antithyroid drug therapy. 5, 2, 1

Specific indications for RAI:

• Elderly patients and those with cardiac disease (should receive RAI immediately after achieving euthyroidism with antithyroid drugs). 5
• Patients who relapse after antithyroid drug therapy (approximately 50% of patients). 3
• Patients who cannot tolerate antithyroid medications. 1

Absolute contraindications:

• Pregnancy (can cause fetal hypothyroidism if exposure occurs after 10 weeks gestation). 4
• Breastfeeding (must wait 4 months after RAI treatment before resuming). 4

Important caveat: RAI is associated with development or worsening of thyroid eye disease in 15-20% of patients. 1 Consider surgery instead in patients with moderate to severe thyroid eye disease. 1

Expected outcome: Hypothyroidism is the inevitable and intended consequence, requiring lifelong levothyroxine replacement. 5, 1

Thyroidectomy (Near-Total or Total)

Surgery is the treatment of choice in specific clinical scenarios:

Absolute indications:

• Suspected or confirmed thyroid malignancy. 5, 1
• Coexisting hyperparathyroidism requiring surgical intervention. 1
• Pregnancy or breastfeeding (when antithyroid drugs cannot be used). 5
• Large goiter (>80 grams) or compressive symptoms. 5, 1
• Severe toxic reactions to antithyroid medications. 5
• Age younger than 5 years. 5
• Moderate to severe thyroid eye disease (to avoid RAI-induced worsening). 5, 1

Relative indications:

• Patient preference for immediate disease control. 5, 1
• Younger patients who prefer definitive treatment. 5

Surgical risks to discuss with patients:

• Hypoparathyroidism (permanent in small proportion). 1
• Vocal cord paralysis from recurrent laryngeal nerve damage. 2, 1
• Risk is inversely correlated with surgeon experience—refer to high-volume thyroid surgeons. 5

Special Populations

Pregnancy

Propylthiouracil is preferred in the first trimester due to limited placental transfer, though recent evidence shows similar fetal outcomes with methimazole. 4

• Goal: Maintain free T4 in the high-normal range using the lowest possible thioamide dose. 4
• Monitor free T4 or free thyroxine index every 2-4 weeks. 4
• Fetal thyroid suppression from thioamides is usually transient and rarely requires treatment. 4
• Alert the newborn's physician about maternal Graves' disease due to risk of neonatal thyroid dysfunction. 4
• Some women opt for definitive RAI or surgery prior to conception to avoid antithyroid drug exposure during pregnancy. 1

Thyroid Storm

This life-threatening emergency requires immediate treatment without waiting for confirmatory lab results:

Standard drug regimen:

• Propylthiouracil or methimazole. 4
• Saturated solution of potassium iodide, sodium iodide, or Lugol's solution. 4
• Dexamethasone. 4
• Beta-blocker (propranolol). 4
• Supportive care: oxygen, antipyretics, appropriate monitoring. 4

Treatment Algorithm

1. Initial assessment: Confirm diagnosis with suppressed TSH and elevated free T4/T3. 4

2. Start antithyroid drugs (methimazole preferred) plus beta-blocker for symptomatic control in most patients. 4, 2, 1

3. After 12-18 months of antithyroid drug therapy:

   • If remission achieved (approximately 50% of patients): monitor for relapse. 3, 1
   • If relapse occurs: offer definitive therapy (RAI or surgery). 3

4. Choose definitive therapy based on:

   • RAI: Preferred for most adults, especially elderly and cardiac patients; avoid in thyroid eye disease. 5, 1
   • Surgery: Preferred for large goiters, suspicious nodules, pregnancy/breastfeeding, thyroid eye disease, or patient preference. 5, 1

5. Post-treatment: Expect hypothyroidism requiring lifelong levothyroxine replacement with both RAI and surgery. 5, 1